Close Menu

Sequenta

NEW YORK (GenomeWeb News) – Sequenta has gained the exclusive rights to iRepertoire's IP related to methods of immune cell sequencing for minimal residual disease testing, the two companies said today.

NEW YORK (GenomeWeb News) – Sequenta has completed a Series C financing round, raising $20 million, it said on Tuesday.

At recent clinical meetings, two firms — Sequenta and Chronix Biomedical — presented data illustrating the distinct next-generation sequencing-based strategies each is taking to monitor minimal residual disease in cancer patients.

The University of Washington and Seattle Cancer Care Alliance have launched UW-Onco-Plex, a sequencing-based test to help guide treatment for cancer patients.

With CLIA certification and several validation studies under its belt, Sequenta is gearing up for the 2013 launch of its sequencing-based test to detect minimal residual disease in cancer patients.

NEW YORK (GenomeWeb News) – Sequenta said today it has received CLIA certification for a clinical test based on in its immune repertoire sequencing-based technology called LymphoSight.

NEW YORK (GenomeWeb News) – Myriad Genetics said in its quarterly filing with the US Securities and Exchange Commission that it has leased approximately 8,300 square feet of lab and office space in Saranac Lake, NY.

Sequenta's sequencing assay to measure residual disease is now being tested in two clinical trials for mantle cell lymphoma.

NEW YORK (GenomeWeb News) – Affymetrix said in its quarterly filing with the US Securities and Exchange Commission this week that it has placed $25.2 million of the purchase price for eBioscience into escrow to cover indemnification obligations tied to litigation brought against eBioscience by Li

By Tony Fong
NEW YORK (GenomeWeb News) – Having demonstrated the utility of its technology, molecular diagnostics firm Sequenta will focus on clinical validation of its technology in 2012 with an expected launch of its first product next year.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.